Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152197 | SCV000200950 | uncertain significance | not specified | 2013-08-15 | criteria provided, single submitter | clinical testing | The Val26701Ile variant in TTN has not been reported in individuals with cardiom yopathy or in large population studies. Computational analyses (biochemical amin o acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. Additional information i s needed to fully assess the clinical significance of the Val26701Ile variant. |
Gene |
RCV000828891 | SCV000970595 | likely benign | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Revvity Omics, |
RCV000828891 | SCV003822221 | uncertain significance | not provided | 2019-10-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000828891 | SCV001921923 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000828891 | SCV001974717 | uncertain significance | not provided | no assertion criteria provided | clinical testing |